Deucravacitinib
2024-452
Unknown small_molecule terminated
Quick answer
Deucravacitinib for Palmoplantar Pustulosis is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Palmoplantar Pustulosis
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated